Study guide
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards
Key Takeaways Explain This Topic AI
The CoC 2020 Standards have nine chapters, from Institutional Administrative Commitment (Chapter 1) and Program Scope and Governance (Chapter 2) through Data Surveillance and Systems (Chapter 6) and Research (Chapter 9).
A Community Cancer Program accessions more than 100 but fewer than 500 newly diagnosed cases a year, a Comprehensive Community Cancer Program 500 or more, and a Hospital Associate Cancer Program 100 or fewer.
A category is kept unless the program's services or caseload change for three consecutive years.
Standard 9.1 sets minimum annual clinical research accrual by category: ACAD 6%, INCP 6%, CCCP 4%, CCP 2%, FCCP 2%, VACP 2%, PCP 50%; HACP and NCIP programs are exempt.
A renewal program that is noncompliant on at least one but fewer than 20% of rated standards is "Accredited – Corrective Action Required" and has one year to resolve the deficiencies.
Last updated: September 2026
The Commission on Cancer
The Commission on Cancer (CoC) of the American College of Surgeons was founded in 1922. It has more than 100 members representing more than 50 national professional organizations and accredits about 1,500 cancer programs in the United States and Puerto Rico. Accreditation requires an on-site review every three years , annual compliance with the standards, and data reporting to the National Cancer Database (NCDB).
How the 2020 standards are organized
Optimal Resources for Cancer Care (2020 Standards) took effect in January 2020 and was updated in October 2025. Its nine chapters are:
- Chapter Title Examples of standards
- 1 Institutional Administrative Commitment 1.1 Administrative Commitment
2 Program Scope and Governance 2.1 Cancer Committee; 2.2 Cancer Liaison Physician; 2.3 Meetings; 2.4 Attendance; 2.5 Multidisciplinary Cancer Case Conference
3 Facilities and Equipment Resources 3.1 Facility Accreditation; 3.2 Evaluation and Treatment Services
4 Personnel and Services Resources 4.1 Physician Credentials; 4.2 Oncology Nursing Credentials; 4.3 Cancer Registry Staff Credentials; 4.4 Genetic Counseling and Risk Assessment; 4.5 Palliative Care; 4.6 Rehabilitation; 4.7 Oncology Nutrition; 4.8 Survivorship Program
5 Patient Care: Expectations and Protocols 5.1 CAP Synoptic Reporting; 5.2 Psychosocial Distress Screening; 5.3–5.8 operative standards (breast sentinel node biopsy, axillary dissection, melanoma wide excision, colon resection, total mesorectal excision, pulmonary resection); 5.9 Smoking Cessation
6 Data Surveillance and Systems 6.1 Cancer Registry Quality Control; 6.4 Rapid Cancer Reporting System: Data Submission; 6.5 Follow-Up of Patients (6.2 Data Submission and 6.3 Data Accuracy were retired in 2021)
7 Quality Improvement 7.1 Quality Measures; 7.2 Monitoring Concordance with Evidence-Based Guidelines; 7.3 Quality Improvement Initiative; 7.4 Cancer Program Goal
8 Education: Professional and Community Outreach 8.1 Addressing Barriers to Care; 8.2 Cancer Prevention Event; 8.3 Cancer Screening Event
9 Research 9.1 Clinical Research Accrual; 9.2 CoC Special Studies
The registry is closest to Chapters 2, 4 (4.3), 6 and 7, but it supplies data for almost every standard. Beyond the core categories, the CoC also offers newer options such as Rural Accreditation and a Pediatric Designation; a new program must be able to show a full calendar year of abstracted registry data before its first site visit.
Program categories
Categories are assigned at the initial application, based on the type of facility, program structure, services and the number of cases accessioned. A category is retained unless the services provided and/or the caseload change for three consecutive years .
Category Key features (per the CoC category definitions)
CCP – Community Cancer Program More than 100 but fewer than 500 newly diagnosed cancer cases a year; the full range of services on-site or by referral
CCCP – Comprehensive Community Cancer Program 500 or more newly diagnosed cancer cases a year; a broad range of services on-site or by referral
ACAD – Academic Comprehensive Cancer Program More than 500 newly diagnosed cases a year and participation in postgraduate medical education (residency) programs
INCP – Integrated Network Cancer Program Multiple facilities that form an integrated network and seek accreditation as one program under the CoC's INCP/NCIN guidelines
NCIP – NCI-Designated Comprehensive Cancer Center Program Holds an NCI Cancer Center Support Grant and is designated a Comprehensive Cancer Center by the NCI
NCIN – NCI-Designated Network Cancer Program A network whose facilities hold an NCI support grant as a designated comprehensive cancer center consortium
FCCP – Free Standing Cancer Center Program A non-hospital-based program offering at least one cancer treatment modality; referral to CoC-accredited programs is preferred
HACP – Hospital Associate Cancer Program 100 or fewer newly diagnosed cancer cases a year, with a limited range of diagnostic and treatment services on-site
PCP – Pediatric Cancer Program A pediatric facility or program with the full range of pediatric services and required participation in clinical trials
VACP – Veterans Affairs Cancer Program Serves military veterans, with the full range of services on-site or by referral
Category drives the research accrual target (Standard 9.1)
- Category Minimum % of patients accrued to cancer-related clinical research each year
- ACAD 6%
- INCP 6%
- CCCP 4%
- CCP 2%
- FCCP 2%
- VACP 2%
- PCP 50%
- HACP, NCIP Exempt
The Clinical Research Coordinator reports annual enrollment to the cancer committee in the first quarter of the following year. Standard 9.1 counts several kinds of cancer-related research, including treatment, screening, genetic and epidemiological studies and patient registries used in clinical research.
Site visits, ratings and awards
Preparation: programs upload evidence to the Pre-Review Questionnaire (PRQ) , formerly called the Survey Application Record (SAR), using templates, cancer committee minutes and reports with all protected health information removed .
Site visit: a trained CoC site reviewer visits every three years, reviews documentation, meets the cancer committee and the CLP, and attends a cancer conference.
Ratings: each standard is rated Compliant , Noncompliant or Not Applicable by consensus of the site reviewer and CoC staff, with an executive review group adjudicating when needed. Any Noncompliant rating is a deficiency .
Accreditation status When it is awarded Consequences
Accredited Full compliance with all applicable standards after a site visit Listed on "Find an Accredited Program"; certificate awarded
Accredited – Corrective Action Required (renewal programs only) Noncompliant on at least one standard but fewer than 20% of the standards rated Stays listed; one year to resolve; certificate issued when "Accredited" status is reached
Not Accredited – Corrective Action Required (initial applicants only) Noncompliant on four or fewer standards Not listed; one year to resolve; no NCDB access until accredited
Not Accredited Renewal program noncompliant on more than 20% of standards; initial applicant with five or more noncompliant standards; or deficiencies not resolved in time No Quality Portal or NCDB tools; not listed; may reapply as an initial applicant after one calendar year of compliance with all applicable standards
Annual compliance timing
Standards judged on a full year of data (2.5, 4.4, 4.5, 4.8, 5.2 and 9.1) must be reported at the first-quarter committee meeting of the following year. Activity-based standards (2.2, 5.1, 5.9, 6.1, 6.4, 7.1, 7.2, 7.3, 7.4, 8.2 and 8.3) must be presented within the calendar year of the activity and cannot be carried into the next year's first quarter. The registrar usually keeps the compliance calendar.